Zobrazeno 1 - 10 of 45 pro vyhledávání: '"Gelder, T. Van"'
1
Therapeutic Drug Monitoring and Dosage Adjustments of Immunosuppressive Drugs When Combined With Nirmatrelvir/Ritonavir in Patients With COVID-19
Autor: Lemaitre, F., Budde, K., Gelder, T. van, Bergan, S., Lawson, R., Noceti, O., Venkataramanan, R., Elens, L., Moes, D.J.A.R., Hesselink, D.A., Pawinski, T., Johnson-Davis, K.L., Winter, B.C.M. de, Pattanaik, S., Brunet, M., Masuda, S., Langman, L.J.
Publikováno v: Therapeutic Drug Monitoring
Therapeutic Drug Monitoring, 2022, ⟨10.1097/FTD.0000000000001014⟩
Therapeutic Drug Monitoring, 45(2), 191-199. LIPPINCOTT WILLIAMS & WILKINS
Therapeutic Drug Monitoring, Vol. 45, no.2, p. 191-199 (2023)
International audience; Nirmatrelvir/ritonavir (Paxlovid®) consists of a peptidomimetic inhibitor (Nirmatrelvir) of the SARS-CoV-2 main protease and a pharmacokinetic enhancer (Ritonavir). It is approved for the treatment of mild-to-moderate COVID-1
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43bcc75bc32e1b83e785c720267a1011
https://doi.org/10.1097/ftd.0000000000001014
Zobrazit plný text záznamu
2
Mycophenolic Acid Exposure Determines Antibody Formation Following SARS‐CoV ‐2 Vaccination in Kidney Transplant Recipients: A Nested Cohort Study
Autor: Meziyerh, S., Bouwmans, P., Gelder, T. van, Helm, D. van der, Messchendorp, L., Boog, P.J.M. van der, Fijter, J.W. de, Moes, D.J.A.R., Vries, A.P.J. de, RECOVAC Collaborators
Publikováno v: Clinical Pharmacology & Therapeutics. WILEY
Clinical Pharmacology & Therapeutics
Clinical Pharmacology & Therapeutics. Wiley
Despite (repeated) boosting, kidney transplant recipients (KTRs) may remain at increased risk of severe COVID-19 since a substantial number of individuals remain seronegative or with low antibody titers. In particular, mycophenolic acid use has been
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd9745103e347bef12e5667d7e7d55fe
https://doi.org/10.1002/cpt.2872
Zobrazit plný text záznamu
3
Why We Need to Take a Closer Look at Genetic Contributions to CYP3A Activity
Autor: Zhai, Q.L., Lee, M. van der, Gelder, T. van, Swen, J.J.
Publikováno v: Frontiers in Pharmacology, 13. FRONTIERS MEDIA SA
Cytochrome P450 3A (CYP3A) subfamily enzymes are involved in the metabolism of 40% of drugs in clinical use. Twin studies have indicated that 66% of the variability in CYP3A4 activity is hereditary. Yet, the complexity of the CYP3A locus and the lack
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e979d5ac0a5a09caec19632f92e133e9
http://hdl.handle.net/1887/3515280
Zobrazit plný text záznamu
4
Resistant hypertension improved after 3 and 6 months by measuring drug levels to identify non-adherence
Autor: Peeters, Laura, Kappers, M. H.W., Hesselink, D. A., Net, J. B.Van Der, Hartong, S. C.C., Bahmany, S., Massay, E., Dijk, L. Van, Gelder, T. Van, Koch, B. C.P., Versmissen, J.
Publikováno v: Journal of Hypertension, 40, e307-e308. Lippincott Williams & Wilkins
OBJECTIVE: Identification of non-adherence to antihypertensive drugs is crucial to improve resistant hypertension (RH). For this measuring drug levels is the most reliable method.The primary objective of this analysis is to determine whether drug lev
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94d56a4046f07c924a3f9aed05d84155
https://pure.eur.nl/en/publications/9844c248-e6be-4a0d-8f2f-af88a3792c0c
Zobrazit plný text záznamu
6
P2-17-04: Induction of Tamoxifen Metabolism by Rifampicin: A Worrying Drug-Drug Interaction
Autor: Jaap Verweij, L Binkhorst, Caroline Seynaeve, Jongh Fe de, Paul Hamberg, Ron H.J. Mathijssen, Walter J. Loos, Gelder T van, Agnes Jager, Moghaddam-Helmantel Im Ghobadi
Publikováno v: Cancer Research. 71:P2-17
Background Tamoxifen (Tam) undergoes extensive biotransformation into several metabolites, including the highly active metabolite endoxifen. Differences in metabolism, influenced by both genetic and environmental factors, largely contribute to the in
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::65326212a9b4c552e5908a45162de9ee
https://doi.org/10.1158/0008-5472.sabcs11-p2-17-04
Zobrazit plný text záznamu
7
Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy: a randomized, prospective, multicenter study
Autor: Gregoor, P.J.H.S., Sevaux, R.G.L. de, Ligtenberg, G., Hoitsma, A.J., Hene, R.J., Weimar, W., Hilbrands, L.B., Gelder, T. van
Publikováno v: Journal of the American Society of Nephrology, 13, 5, pp. 1365-73
Journal of the American Society of Nephrology, 13, 1365-73
Item does not contain fulltext Uncertainty exists regarding the necessity of continuing triple therapy consisting of mycophenolate mofetil (MMF), cyclosporine (CsA), and prednisone (Pred) after kidney transplantation (RTx). At 6 mo after RTx, 212 pat
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::58f9e17e5f783cadadf45416edaeefdf
https://hdl.handle.net/2066/185534
Zobrazit plný text záznamu
8
Mycofenolzuur: veelbelovend immunosuppresivum na orgaantransplantatie
Autor: Gelder, T. van, Smak Gregoor, P.J.H., Hene, R.J., Sevaux, R.G.L. de, Hilbrands, L.B.
Publikováno v: Nederlands Tijdschrift voor Geneeskunde, 142, 27, pp. 1550-1554
Nederlands Tijdschrift voor Geneeskunde, 142, 1550-1554
Item does not contain fulltext
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3c2a4812628453f5262b72cfff9ab0fa
https://hdl.handle.net/2066/163899
Zobrazit plný text záznamu
10
The optimal architecture for simulating spoken-word recognition
Autor: Norris, D., Cutler, A., McQueen, J.M., Davis, C., Gelder, T. van, Wales, R.
Publikováno v: C. Davis, T. van Gelder & R. Wales (Eds.), Cognitive Science in Australia, 2000: Proceedings of the Fifth Biennial Conference of the Australasian Cognitive Science Society [CD-ROM]
Davis, C.; Gelder, T. van; Wales, R. (ed.), Cognitive Science in Australia, 2000: Proceedings of the Fifth Biennial Conference of the Australasian Cognitive Science Society
C. Davis, T. van Gelder & R. Wales (Eds.), Cognitive Science in Australia, 2000: Proceedings of the Fifth Biennial Conference of the Australasian Cognitive Science Society [CD-ROM]. Causal Productions
Cognitive Science in Australia, 2000: Proceedings of the Fifth Biennial Conference of the Australasian Cognitive Science Society
Davis, C.; Gelder, T. van; Wales, R. (ed.), Cognitive Science in Australia, 2000: Proceedings of the Fifth Biennial Conference of the Australasian Cognitive Science Society. Adelaide : Causal Productions
Simulations explored the inability of the TRACE model of spoken-word recognition to model the effects on human listening of subcategorical mismatch in word forms. The source of TRACE's failure lay not in interactive connectivity, not in the presence
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::78bd60256e41a39e3546336673373271
https://hdl.handle.net/2066/16992
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje